Bill Kristol

our future i mean to our medical future to our future in innovation and technology to our competitive future is there a single complex of of policies the universities immigration rfk junior in charge of of health the medicaid cuts the healthcare cuts in general is there a stronger case of self-inflicted damage to the future of this country and it's all unambiguous insanity like there's no downside

to having the most professional treatment of vaccines possible and the best scientific and medical knowledge. There's no downside to having more and more people come and study here and participate in scientific and medical progress and also just medical research. providing medical care for people.

to having the most professional treatment of vaccines possible and the best scientific and medical knowledge. There's no downside to having more and more people come and study here and participate in scientific and medical progress and also just medical research. providing medical care for people.

to having the most professional treatment of vaccines possible and the best scientific and medical knowledge. There's no downside to having more and more people come and study here and participate in scientific and medical progress and also just medical research. providing medical care for people.

You know, there's no downside to what we've been doing, honestly, with universities in terms of biomedical research and leading the world for 40, 50 years. Sometimes policy areas, as you well know, have trade-offs and there's kind of like, oh, it's a little bit of a tough call and maybe we, government's expanded too much here and stuff.

You know, there's no downside to what we've been doing, honestly, with universities in terms of biomedical research and leading the world for 40, 50 years. Sometimes policy areas, as you well know, have trade-offs and there's kind of like, oh, it's a little bit of a tough call and maybe we, government's expanded too much here and stuff.

You know, there's no downside to what we've been doing, honestly, with universities in terms of biomedical research and leading the world for 40, 50 years. Sometimes policy areas, as you well know, have trade-offs and there's kind of like, oh, it's a little bit of a tough call and maybe we, government's expanded too much here and stuff.

This is like one of the least ambiguous policy areas, broadly speaking, I think, that one could think of. And we're doing what we can to damage ourselves, I think.

This is like one of the least ambiguous policy areas, broadly speaking, I think, that one could think of. And we're doing what we can to damage ourselves, I think.

This is like one of the least ambiguous policy areas, broadly speaking, I think, that one could think of. And we're doing what we can to damage ourselves, I think.

Nein, ich glaube, er würde das akzeptieren. George H. W. Bush, White House, Vice President Quayle was in charge of something called the Competitiveness Council. One of the things we tried to do was speed up the approval of drugs to sort of make the whole NIH, CDC, FDA process, which is a complicated process, but important, obviously.

Nein, ich glaube, er würde das akzeptieren. George H. W. Bush, White House, Vice President Quayle was in charge of something called the Competitiveness Council. One of the things we tried to do was speed up the approval of drugs to sort of make the whole NIH, CDC, FDA process, which is a complicated process, but important, obviously.

Nein, ich glaube, er würde das akzeptieren. George H. W. Bush, White House, Vice President Quayle was in charge of something called the Competitiveness Council. One of the things we tried to do was speed up the approval of drugs to sort of make the whole NIH, CDC, FDA process, which is a complicated process, but important, obviously.

You want safe drugs and drugs that are effective, as promised, and so forth. But to speed that up and to streamline it a bit, I guess, that was a more traditional conservative approach.

You want safe drugs and drugs that are effective, as promised, and so forth. But to speed that up and to streamline it a bit, I guess, that was a more traditional conservative approach.

You want safe drugs and drugs that are effective, as promised, and so forth. But to speed that up and to streamline it a bit, I guess, that was a more traditional conservative approach.

critique of big liberal bureaucracies or just big bureaucracy let's just say and it was a reasonable one at the time and i think we did a fair amount that's kind of a technocratic critique right like obama administration had an effort to do that same thing right right and people like us pointed out and i think people pointed this out both on the left and the right and this is very much of a case where you could have a centrist agenda going forward that would be quite you know

critique of big liberal bureaucracies or just big bureaucracy let's just say and it was a reasonable one at the time and i think we did a fair amount that's kind of a technocratic critique right like obama administration had an effort to do that same thing right right and people like us pointed out and i think people pointed this out both on the left and the right and this is very much of a case where you could have a centrist agenda going forward that would be quite you know

critique of big liberal bureaucracies or just big bureaucracy let's just say and it was a reasonable one at the time and i think we did a fair amount that's kind of a technocratic critique right like obama administration had an effort to do that same thing right right and people like us pointed out and i think people pointed this out both on the left and the right and this is very much of a case where you could have a centrist agenda going forward that would be quite you know

healthy, that, you know, why is it that we suspend a lot of these regulations when we really have an emergency and want to produce drugs, whether for the pandemic or for AIDS?